NCT07407920 2026-02-12Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR TrialM.D. Anderson Cancer CenterPhase 2 Active not recruiting120 enrolled
NCT04329065 2025-11-06Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast CancerUniversity of WashingtonPhase 2 Recruiting25 enrolled